Edition:
United States

Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

0.95USD
19 Oct 2018
Change (% chg)

$-0.06 (-5.53%)
Prev Close
$1.01
Open
$1.01
Day's High
$1.01
Day's Low
$0.95
Volume
42,254
Avg. Vol
119,563
52-wk High
$3.30
52-wk Low
$0.47

Latest Key Developments (Source: Significant Developments)

Bellerophon Therapeutics Inc Files For Mixed Shelf Of Up To $100 mln
Tuesday, 26 Jun 2018 11:51am EDT 

June 26 (Reuters) - Bellerophon Therapeutics Inc ::BELLEROPHON THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $100 MILLION – SEC FILING.  Full Article

Bellerophon Q4 Loss Per Share $0.44
Thursday, 15 Mar 2018 04:45pm EDT 

March 15 (Reuters) - Bellerophon Therapeutics Inc ::BELLEROPHON PROVIDES BUSINESS UPDATE AND REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.44.  Full Article

Bellerophon Therapeutics reports Q3 loss per share $0.22
Tuesday, 7 Nov 2017 08:30am EST 

Nov 7 (Reuters) - Bellerophon Therapeutics Inc :Bellerophon provides business update and reports third quarter 2017 financial results.Q3 loss per share $0.22.Says ‍ phase 2a study for inopulse met its primary endpoint​.  Full Article

Bellerophon Therapeutics says selling stockholders may offer, resell up to 38.9 mln shares - SEC filing
Tuesday, 24 Oct 2017 05:26pm EDT 

Oct 24 (Reuters) - Bellerophon Therapeutics Inc :Bellerophon Therapeutics Inc files to say selling stockholders may offer and resell up to 38.9 million shares of co's common stock - SEC filing.Bellerophon Therapeutics Inc - the selling stockholders will receive all of the proceeds from any sales of the shares offered.  Full Article

BRIEF-Bellerophon Therapeutics Q1 Shr Loss $0.04

* BELLEROPHON PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS